혈액종양내과한보람 교수 사진

한보람

진료과 : 혈액종양내과 홈페이지

전문진료분야 : 소화기암, 기타암질환, 빈혈

학력 및 경력

내용 숨기기
학력
한림대학교 의과대학 의예과 (1998)
한림대학교 의과대학 의학과 (2005)
한림대학교성심병원 인턴 수료 (2006)
한림대학교 의과대학 내과학 석사 졸업 (2010)

경력
한림대학교성심병원 내과 전공의 (2010)
삼성서울병원 혈액종양내과 임상강사 (2011)
서울아산병원 혈액종양내과 임상강사 (2011.08)
現한림대학교성심병원 혈액종양내과 조교수

수상경력

내용 숨기기
1. Certificate for GCP training for investigators 2010.7.20

2. Completion of clinical trial training & education professional program for investigators 2011.3.8

국내학회지 발표논문

내용 숨기기
1. First Report of a Patient With Natural Killer-Lymphoblastic Leukemia/Lymphoma in Korea (Annals of Laboratory Medicine)

2. Correlation of Thyroid Transcription Factor-1 Expression with EGFR Mutations in Non-Small-Cell Lung Cancer: A Meta-Analysis (MEDICINA-LITHUANIA)

3. Pathological and Prognostic Impacts of FGFR2 Overexpression in Gastric Cancer: A Meta-Analysis (JOURNAL OF CANCER)

4. A Myelodysplastic Syndrome with Concurrent Basophilia and Eosinophilia Lacking Oncogenic Mutations in 54 Relevant Genes (CLINICAL LABORATORY)

5. Multicenter Phase II Study of Oxaliplatin, Irinotecan, and S-1 as First-Line Treatment for Patients with Recurrent or Metastatic Biliary Tract Cancer (CANCER RESEARCH AND TREATMENT)

6. Phase II study of oxaliplatin, irinotecan and S-1 therapy in patients with advanced gastric cancer: the Korean Cancer Study Group ST14-11 (GASTRIC CANCER)

7. Clinicopathologic Significance of VHL Gene Alteration in Clear-Cell Renal Cell Carcinoma: An Updated Meta-Analysis and Review (INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES)

8. Prognostic Impact of TTF-1 Expression in Non-Squamous Non-Small-Cell Lung Cancer: A Meta-Analysis (JOURNAL OF CANCER)

9. A multicenter, retrospective analysis of elderly patients with acute myeloid leukemia who were treated with decitabine (Oncotarget)

10. A dose-finding study for oxaliplatin, irinotecan, and S-1 (OIS) in patients with metastatic or recurrent gastrointestinal cancer (CANCER CHEMOTHERAPY AND PHARMACOLOGY)